Cargando…
Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial
BACKGROUND: Infusion therapy is one of the most frequently prescribed medications in hospitalized patients. Currently used crystalloid solutes have a variable composition and may therefore influence acid-base status, intracellular and extracellular water content and plasma electrolyte compositions a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599439/ https://www.ncbi.nlm.nih.gov/pubmed/28255797 http://dx.doi.org/10.1007/s00508-017-1180-4 |
_version_ | 1783264056065392640 |
---|---|
author | Pfortmueller, Carmen Funk, Georg-Christian Potura, Eva Reiterer, Christian Luf, Florian Kabon, Barbara Druml, Wilfred Fleischmann, Edith Lindner, Gregor |
author_facet | Pfortmueller, Carmen Funk, Georg-Christian Potura, Eva Reiterer, Christian Luf, Florian Kabon, Barbara Druml, Wilfred Fleischmann, Edith Lindner, Gregor |
author_sort | Pfortmueller, Carmen |
collection | PubMed |
description | BACKGROUND: Infusion therapy is one of the most frequently prescribed medications in hospitalized patients. Currently used crystalloid solutes have a variable composition and may therefore influence acid-base status, intracellular and extracellular water content and plasma electrolyte compositions and have a major impact on organ function and outcome. The aim of our study was to investigate whether use of acetate-based balanced crystalloids leads to better hemodynamic stability compared to 0.9% saline. METHODS: We performed a sub-analysis of a prospective, randomized, controlled trial comparing effects of 0.9% saline or an acetate-buffered, balanced crystalloid during the perioperative period in patients with end-stage renal disease undergoing cadaveric renal transplantation. Need for catecholamine therapy and blood pressure were the primary measures. RESULTS: A total of 150 patients were included in the study of which 76 were randomized to 0.9% saline while 74 received an acetate-buffered balanced crystalloid. Noradrenaline for cardiocirculatory support during surgery was significantly more often administered in the normal saline group, given earlier and with a higher cumulative dose compared to patients receiving an acetate-buffered balanced crystalloid (30% versus 15%, p = 0.027; 68 ± 45 µg/kg versus 75 ± 60 µg/kg, p = 0.0055 and 0.000492 µg/kg body weight/min, ±0.002311 versus 0.000107 µg/kg/min, ±0.00039, p = 0.04, respectively). Mean minimum arterial blood pressure was significantly lower in patients randomized to 0.9% saline than in patients receiving the balanced infusion solution (57.2 [SD 8.7] versus 60.3 [SD 10.2] mm Hg, p = 0.024). CONCLUSION: The use of an acetate-buffered, balanced infusion solution results in reduced need for use of catecholamines and cumulative catecholamine dose for hemodynamic support and in less occurrence of arterial hypotension in the perioperative period. Further research in the field is strongly encouraged. |
format | Online Article Text |
id | pubmed-5599439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-55994392017-10-03 Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial Pfortmueller, Carmen Funk, Georg-Christian Potura, Eva Reiterer, Christian Luf, Florian Kabon, Barbara Druml, Wilfred Fleischmann, Edith Lindner, Gregor Wien Klin Wochenschr Original Article BACKGROUND: Infusion therapy is one of the most frequently prescribed medications in hospitalized patients. Currently used crystalloid solutes have a variable composition and may therefore influence acid-base status, intracellular and extracellular water content and plasma electrolyte compositions and have a major impact on organ function and outcome. The aim of our study was to investigate whether use of acetate-based balanced crystalloids leads to better hemodynamic stability compared to 0.9% saline. METHODS: We performed a sub-analysis of a prospective, randomized, controlled trial comparing effects of 0.9% saline or an acetate-buffered, balanced crystalloid during the perioperative period in patients with end-stage renal disease undergoing cadaveric renal transplantation. Need for catecholamine therapy and blood pressure were the primary measures. RESULTS: A total of 150 patients were included in the study of which 76 were randomized to 0.9% saline while 74 received an acetate-buffered balanced crystalloid. Noradrenaline for cardiocirculatory support during surgery was significantly more often administered in the normal saline group, given earlier and with a higher cumulative dose compared to patients receiving an acetate-buffered balanced crystalloid (30% versus 15%, p = 0.027; 68 ± 45 µg/kg versus 75 ± 60 µg/kg, p = 0.0055 and 0.000492 µg/kg body weight/min, ±0.002311 versus 0.000107 µg/kg/min, ±0.00039, p = 0.04, respectively). Mean minimum arterial blood pressure was significantly lower in patients randomized to 0.9% saline than in patients receiving the balanced infusion solution (57.2 [SD 8.7] versus 60.3 [SD 10.2] mm Hg, p = 0.024). CONCLUSION: The use of an acetate-buffered, balanced infusion solution results in reduced need for use of catecholamines and cumulative catecholamine dose for hemodynamic support and in less occurrence of arterial hypotension in the perioperative period. Further research in the field is strongly encouraged. Springer Vienna 2017-03-02 2017 /pmc/articles/PMC5599439/ /pubmed/28255797 http://dx.doi.org/10.1007/s00508-017-1180-4 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Pfortmueller, Carmen Funk, Georg-Christian Potura, Eva Reiterer, Christian Luf, Florian Kabon, Barbara Druml, Wilfred Fleischmann, Edith Lindner, Gregor Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial |
title | Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial |
title_full | Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial |
title_fullStr | Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial |
title_full_unstemmed | Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial |
title_short | Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: Prospective, randomized, controlled trial |
title_sort | acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation: prospective, randomized, controlled trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599439/ https://www.ncbi.nlm.nih.gov/pubmed/28255797 http://dx.doi.org/10.1007/s00508-017-1180-4 |
work_keys_str_mv | AT pfortmuellercarmen acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial AT funkgeorgchristian acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial AT poturaeva acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial AT reitererchristian acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial AT lufflorian acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial AT kabonbarbara acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial AT drumlwilfred acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial AT fleischmannedith acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial AT lindnergregor acetatebufferedcrystalloidinfusateversusinfusionof09salineandhemodynamicstabilityinpatientsundergoingrenaltransplantationprospectiverandomizedcontrolledtrial |